Cover Image
市場調查報告書

組織診斷的全球市場:2016∼2020年

Global Tissue Diagnostics Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 317834
出版日期 內容資訊 英文 72 Pages
訂單完成後即時交付
價格
Back to Top
組織診斷的全球市場:2016∼2020年 Global Tissue Diagnostics Market 2016-2020
出版日期: 2016年02月24日 內容資訊: 英文 72 Pages
簡介

組織診斷,是抽出特定的組織來分析,進行疾病診斷的同時也分析生物學的要素。在臨床研究、臨床診斷、細胞生物學中廣泛使用。全球組織診斷市場,預計2016∼2020年以年複合成長率11.59%擴大。

本報告提供全球組織診斷市場現狀與今後的成長預測,各技術,各產品,各疾病,及各地區趨勢,以及市場趨勢與課題,主要供應商等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 全球癌症統計

第6章 償付與補償:概要

  • 目前方案:診斷檢驗的有效性評估
  • 美國的報銷問題
  • EU的償付
  • 償付政策的課題

第7章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第8章 各技術市場區隔

  • 各最新染色
  • 各數位病理學
  • 分析前及定期染色

第9章 各產品市場區隔

  • 消耗品
  • 設備

第10章 各疾病市場區隔

  • 乳癌
  • 肺癌
  • 大腸癌
  • 淋巴瘤
  • 子宮頸癌
  • 前列腺癌
  • 其他

第11章 各終端用戶市場區隔

  • 醫院
  • CRO
  • 學術、研究機關

第12章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第13章 推動市場的要素

第14章 促進要素的影響

第15章 市場課題

第16章 促進要素及課題的影響

第17章 市場趨勢

第18章 供應商環境

  • 競爭模式
  • 市場佔有率分析

第19章 附錄

第20章 關於Technavio

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR8799

About Tissue Diagnostics

Tissue diagnostics involves the diagnosis of diseases or analysis of the biological causes of the disease by extracting and analyzing a specific tissue. It has a broad range of applications in clinical research, clinical diagnostics, and cell biology. It is considered one of the most accurate techniques for the diagnosis of inflammatory conditions. Medical specialists particularly use tissue diagnostics in the area of molecular biology for cancer screening, therapy selection, diagnosis, and relapse monitoring. It helps in the screening and diagnosis of lymphoma, melanoma, leukemia, and breast, ovarian, cervical, head and neck, pancreatic, non-small cell lung, colorectal, brain, prostate, lung, and endometrial cancers. Pathologists use different technologies such as in situ hybridization (ISH), immunohistochemistry (IHC), special staining, and digital pathology and related methods including core biopsy, fine needle aspiration cytology, and open biopsy to study and diagnose cells.

Technavio's analysts forecast the global tissue diagnostics market to grow at a CAGR of 11.59% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global tissue diagnostics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of diagnostic devices based on the following techniques:

  • Advanced staining
  • Preanalytical and routine staining
  • Digital pathology

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Tissue Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Diagnostics
  • Agilent Technologies (a parent company of Dako)
  • Danaher (a parent company of Leica Biosystems)
  • Roche Diagnostics

Other Prominent Vendors

  • 20/20 GeneSystems
  • Abcam
  • AdnaGen
  • Advanced Cell Diagnostics
  • Affymetrix
  • Agendia
  • AutoGenomics
  • AVIVA BioSciences
  • Biocare Medical
  • Biocartis
  • Cancer Genetics
  • ELITechGroup
  • Enzo Biochem
  • Epic Sciences
  • Fluidigm
  • HORIBA Medical
  • Janssen Diagnostics
  • Olympus Diagnostics Systems Group
  • Omnyx (a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, US)
  • Oxford Gene Technology
  • PANAGENE
  • Protea Biosciences Group
  • Sakura Finetek

Market driver

  • Implementation by new customers
  • For a full, detailed list, view our report

Market challenge

  • Insurance coverage and reimbursement issues
  • For a full, detailed list, view our report

Market trend

  • Ready-to-use reagents
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Global cancer statistics

PART 06: Reimbursement and coverage: An overview

  • Current scenario: Validating diagnostic tests
  • Reimbursement structure in US
  • Reimbursement structure in EU
  • Prevailing issues of reimbursement policies

PART 07: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 08: Market segmentation by technology

  • Global tissue diagnostics market by advanced staining
  • Global tissue diagnostics market by digital pathology
  • Global tissue diagnostics market by preanalytical and routine staining

PART 09: Market segmentation by product

  • Global tissue diagnostics market segmentation by consumables
  • Global tissue diagnostics market segmentation by instruments

PART 10: Market segmentation by disease

  • Breast cancer
  • Lung cancer
  • Colorectal cancer
  • Lymphoma
  • Cervical cancer
  • Prostate cancer
  • Other diseases

PART 11: Market segmentation by end-user

  • Hospitals
  • CROs
  • Academia and research institutes

PART 12: Geographical segmentation

  • Tissue diagnostics market in Americas
  • Tissue diagnostics market in EMEA
  • Tissue diagnostics market in APAC

PART 13: Market drivers

  • Prevalence of chronic diseases
  • Implementation by new consumers
  • Use of biomarkers for disease diagnosis
  • Demand for personalized medicine

PART 14: Impact of drivers

PART 15: Market challenges

  • Insurance coverage and reimbursement issues
  • Limitations of closed systems
  • High initial investment and maintenance costs

PART 16: Impact of drivers and challenges

PART 17: Market trends

  • Ready-to-use reagents
  • Focus on system automation
  • Increase in M&A

PART 18: Vendor landscape

  • Competitive scenario
  • Market share analysis 2015

PART 19: Appendix

  • List of abbreviations

PART 20: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Prevalent cancer types worldwide 2012
  • Exhibit 03: Countries with highest cancer rate 2012
  • Exhibit 04: Cancer statistics by gender 2012
  • Exhibit 05: Reimbursement perspectives of healthcare entities
  • Exhibit 06: Global tissue diagnostics market 2015-2020 ($ billions)
  • Exhibit 07: Five forces analysis
  • Exhibit 08: Global tissue diagnostics market segmentation by technology
  • Exhibit 09: Global tissue diagnostics market segmentation by technology 2015
  • Exhibit 10: Global tissue diagnostics market segmentation by technology 2020
  • Exhibit 11: Global tissue diagnostics market segmentation by technology 2015-2020
  • Exhibit 12: Global tissue diagnostics market segmentation by advanced staining 2015
  • Exhibit 13: Global tissue diagnostics market segmentation by advanced staining 2020
  • Exhibit 14: Global tissue diagnostics market segmentation by advanced staining 2015-2020
  • Exhibit 15: Global tissue diagnostics market by IHC 2015-2020 ($ billions)
  • Exhibit 16: Global tissue diagnostics market by ISH 2015-2020 ($ millions)
  • Exhibit 17: Types of ISH
  • Exhibit 18: Comparative analysis of CISH, FISH, and IHC
  • Exhibit 19: Global tissue diagnostics market by advanced staining 2015-2020 ($ billions)
  • Exhibit 20: Geographical segmentation of global tissue diagnostics market by advanced staining 2015
  • Exhibit 21: Global tissue diagnostics market by digital pathology 2015-2020 ($ billions)
  • Exhibit 22: Geographical segmentation of global tissue diagnostics market by digital pathology 2015
  • Exhibit 23: Global tissue diagnostics market segmentation by preanalytical and routine staining 2015
  • Exhibit 24: Global tissue diagnostics market segmentation by preanalytical and routine staining 2020
  • Exhibit 25: Global tissue diagnostics market segmentation by preanalytical and routine staining 2015-2020
  • Exhibit 26: Global tissue diagnostics market by preanalytical staining 2015-2020 ($ millions)
  • Exhibit 27: Global tissue diagnostics market by H&E staining 2015-2020 ($ millions)
  • Exhibit 28: Common special stains used for histological studies
  • Exhibit 29: Global tissue diagnostics market by special staining 2015-2020 ($ millions)
  • Exhibit 30: Global tissue diagnostics market by preanalytical and routine staining 2015-2020 ($ billions)
  • Exhibit 31: Geographical segmentation of global tissue diagnostics market by preanalytical and routine staining 2015
  • Exhibit 32: Global tissue diagnostics market segmentation by product
  • Exhibit 33: Global tissue diagnostics market segmentation by product 2015
  • Exhibit 34: Global tissue diagnostics market segmentation by product 2020
  • Exhibit 35: Global tissue diagnostics market segmentation by product 2015-2020
  • Exhibit 36: Global tissue diagnostics market by consumables 2015-2020 ($ billions)
  • Exhibit 37: Global tissue diagnostics market by instruments 2015-2020 ($ billions)
  • Exhibit 38: Global tissue diagnostics market segmentation by disease
  • Exhibit 39: Global tissue diagnostics market segmentation by disease type 2015
  • Exhibit 40: Global tissue diagnostics market segmentation by end-user
  • Exhibit 41: Global tissue diagnostics market segmentation by end-user 2015
  • Exhibit 42: Global tissue diagnostics market segmentation by geography 2015
  • Exhibit 43: Global tissue diagnostics market segmentation by geography 2020
  • Exhibit 44: Global tissue diagnostics market segmentation by geography 2015-2020
  • Exhibit 45: Tissue diagnostics market in Americas 2015-2020 ($ billions)
  • Exhibit 46: Segmentation of tissue diagnostics market in Americas by technology 2015
  • Exhibit 47: Tissue diagnostics market in EMEA 2015-2020 ($ billions)
  • Exhibit 48: Segmentation of tissue diagnostics market in EMEA by technology 2015
  • Exhibit 49: Tissue diagnostics market in APAC 2015-2020 ($ millions)
  • Exhibit 50: Segmentation of tissue diagnostics market in APAC by technology 2015
  • Exhibit 51: Impact of drivers
  • Exhibit 52: Impact of drivers and challenges
  • Exhibit 53: Ranking of top vendors 2015
  • Exhibit 54: Roche Diagnostics: Key takeaways
  • Exhibit 55: Agilent Technologies: Key takeaways
  • Exhibit 56: Danaher: Key takeaways
  • Exhibit 57: Abbott Diagnostics: Key takeaways
Back to Top